Page last updated: 2024-11-02

piracetam and Hypoplastic Left Heart Syndrome

piracetam has been researched along with Hypoplastic Left Heart Syndrome in 1 studies

Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.

Hypoplastic Left Heart Syndrome: A condition caused by underdevelopment of the whole left half of the heart. It is characterized by hypoplasia of the left cardiac chambers (HEART ATRIUM; HEART VENTRICLE), the AORTA, the AORTIC VALVE, and the MITRAL VALVE. Severe symptoms appear in early infancy when DUCTUS ARTERIOSUS closes.

Research Excerpts

ExcerptRelevanceReference
"Lacosamide decreases seizure burden by modulating sodium channels."1.42Lacosamide-induced atrial tachycardia in a child with hypoplastic left-heart syndrome: the importance of assessing additional proarrhythmic risks. ( Gudausky, TM; Kovach, J; Loomba, RS; Singh, AK, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Loomba, RS1
Singh, AK1
Kovach, J1
Gudausky, TM1

Other Studies

1 other study available for piracetam and Hypoplastic Left Heart Syndrome

ArticleYear
Lacosamide-induced atrial tachycardia in a child with hypoplastic left-heart syndrome: the importance of assessing additional proarrhythmic risks.
    Cardiology in the young, 2015, Volume: 25, Issue:4

    Topics: Acetamides; Anticonvulsants; Arrhythmias, Cardiac; Child, Preschool; Comorbidity; Humans; Hypoplasti

2015